SCHEDULE: Vanguard Increases Stake in Acadia Healthcare to 10.19%

The Vanguard Group reported an increased beneficial ownership of 10.19% in Acadia Healthcare Co Inc, holding 9,417,045 shares as of September 30, 2025.

Summary

• The Vanguard Group, an investment adviser, reported beneficial ownership of 9,417,045 shares of Acadia Healthcare Co Inc common stock.
• This ownership represents 10.19% of the total class of securities.
• Vanguard holds sole dispositive power over 8,718,595 shares and shared dispositive power over 698,450 shares.
• Vanguard exercises shared voting power over 598,737 shares and holds no sole voting power.
• The securities were acquired and are held in the ordinary course of business, without the purpose or effect of changing or influencing control of the issuer.

Sentiment

Score: 6

Explanation: The filing indicates a significant institutional stake by Vanguard, which is generally viewed as a positive signal of confidence in the company's long-term value, though it is a passive investment.

Positives

• Increased institutional ownership by a major investment firm like Vanguard can signal confidence in Acadia Healthcare's long-term prospects.
• Vanguard's holding is for investment purposes in the ordinary course of business, indicating a passive, long-term investment strategy.

Negatives

• The filing does not indicate any intent by Vanguard to influence or change control of Acadia Healthcare, which might disappoint activist investors seeking strategic shifts.

Industry Context

Increased institutional ownership by a major fund manager like The Vanguard Group is a common occurrence in the healthcare sector, reflecting ongoing investment interest in established companies. Such filings typically indicate a passive investment strategy rather than an activist stance, aligning with the broader trend of large index and passively managed funds accumulating significant stakes across various industries.

Stakeholder Impact

• Shareholders: May view the increased institutional ownership as a vote of confidence, potentially stabilizing or positively influencing share price perception.
• Management: The passive nature of Vanguard's investment suggests no immediate pressure for strategic changes from this particular shareholder.

Key Dates

Recommendation

The Schedule 13G filing indicates a significant, passive institutional investment by The Vanguard Group in Acadia Healthcare. While increased institutional ownership can be a positive signal of long-term confidence, this filing alone does not provide sufficient operational or financial data to warrant a 'buy' or 'sell' recommendation. It primarily reflects a portfolio adjustment by a large asset manager. Therefore, a 'hold' recommendation is appropriate, pending further analysis of Acadia Healthcare's financial performance and strategic initiatives.

Keywords

Acadia Healthcare, Vanguard Group, Institutional Ownership, Common Stock, Schedule 13G, Healthcare Investment, Beneficial Ownership